Overall rank by patents
#47,609
Across all tracked assignees
USPTO PatentsView assignee record - 5 granted patents across 9 technology areas, active 2015–2024. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: B27N (MANUFACTURE BY DRY PROCESSES OF ARTICLES, WITH OR WITHOUT ORGANIC BINDING AGENTS, MADE FROM PARTICLES OR FIBRES CONSISTING OF WOOD OR OTHER LIGNOCELLULOSIC OR LIKE ORGANIC MATERIAL).
The verdict
IMAL holds 5 US patents across 9 technology areas, rank #47,609 of 50,000 tracked assignees.
IMAL S.r.l. has been granted 5 US utility patents between 2015 and 2024, placing IMAL S.r.l. at rank #47,609 across all assignees tracked by PlainPatent. This portfolio spans 9 distinct Cooperative Patent Classification (CPC) subclasses, averaging 7.8 claims per patent with primary concentration in B27N (MANUFACTURE BY DRY PROCESSES OF ARTICLES, WITH OR WITHOUT ORGANIC BINDING AGENTS, MADE FROM PARTICLES OR FIBRES CONSISTING OF WOOD OR OTHER LIGNOCELLULOSIC OR LIKE ORGANIC MATERIAL). As a Foreign Corporation, IMAL S.r.l. is one of the more focused assignees in the PatentsView dataset. By volume, IMAL sits between Ilooda Co., Ltd. (5 patents, rank #47,605) and Immunicom Inc. (5 patents, rank #47,613) - the closest US assignees by grant volume. The composite Innovation Score of 28.1/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 2 grants, compared with 3 in the 2015–2019 window, a -33% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. IMAL S.r.l.'s 7.8 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while concentration in 9 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark IMAL S.r.l. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
ILOODA Co., Ltd.
5 patents
IMABIOTECH
5 patents
IMACTIS
5 patents
IMAGO PHARMACEUTICALS, INC.
5 patents
IMIG, INC.
5 patents
IMMERSON CORPORATION
5 patents
IMMUNEX CORPORATION
5 patents
IMMUNICOM INC.
5 patents
IMAL S.R.L.
5 patents
What this shows IMAL holds 5 patents at rank #47,609, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #47,609 in granted patent volume.
Other assignees with the most granted patents in IMAL's primary technology class.
IMAL's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
28 Top 74% higher than 26% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 1 | 20.0% |
| 2017 | 1 | 20.0% |
| 2018 | 1 | 20.0% |
| 2021 | 1 | 20.0% |
| 2024 | 1 | 20.0% |
Top 9 of 9 technology areas
Overall rank by patents
#47,609
Across all tracked assignees
28.1 out of 100
How to use this portfolio
IMAL's 5 grants land it in the top 74% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.